⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 12, 2024American Journal of Therapeutics

Effects of Mavacamten Concomitant With Beta-Blockers on Patients With Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials

Syeda Tayyaba Rehan Abraish Ali Laiba Imran Jawad Ahmed Irfan Ullah Abdelrahman Sherif Abdalla Muhammad Majid Muhammad Sohaib Asghar

View at Publisher

Ask AI

Bookmark

Share

Design

Meta-analysis of randomized controlled trials

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rehan et al. (2024) studied this question.

synapsesocial.com/papers/6a82c1a2c40fc255ce13408a https://doi.org/10.1097/mjt.0000000000001698

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Efficacy and Safety of Mavacamten in Treatment of Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysismeta-analysis · 2023 · 16 citations
2Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic CardiomyopathyRCT · 2021 · 200 citations
3Analyzing safety and effectiveness of Mavacamten in comparison with placebo for managing hypertrophic cardiomyopathy: a systemic review and meta-analysismeta-analysis · 2023 · 8 citations
4Beta-Blocker Management in Obstructive Hypertrophic Cardiomyopathy Treated with Mavacamten: A Practical Approach.review · 2026
5Efficacy and safety of Mavacamten for symptomatic Hypertrophic cardiomyopathy – an updated Meta-Analysis of randomized controlled trialsmeta-analysis · 2024 · 6 citations
6The effect of mavacamten on echocardiographic parameters, cardiac function and biomarkers in hypertrophic cardiomyopathy patients, a systematic review and meta-analysismeta-analysis · 2025 · 4 citations
7Effect of Beta-Blocker Therapy on the Response to Mavacamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathycohort · 2022 · 52 citations
8Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imagingmeta-analysis · 2024 · 9 citations
9Improvement in mitral regurgitation after alcohol septal ablation in hypertrophic obstructive cardiomyopathy: a retrospective cohort studyBMC Cardiovascular Disorders · 2026
10Beyond Ejection Fraction: Integrating Etiology into Future Heart Failure ClassificationAmerican Journal of Therapeutics · 2026

HMore on Hypertrophic cardiomyopathy

More from American Journal of Therapeutics

More from Dow University of Health Sciences

More from Gandhara University

More from AdventHealth Sebring